progress in Recombinant Human Serum Albumin for Biopharmaceutical purposes
Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sphere of biopharmaceuticals, offering promising breakthroughs throughout a variety of clinical and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA offers a safer, far more reliable alternative for therapeutic use,